Suhila Sawesi

Dr. Suhila Sawesi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2016 in JMIR Medical Informatics
Verified
Journal Article
Open access
Suhila SawesiSuhila Sawesi
Suhila Sawesi
MRMohamed Rashrash
Mohamed Rashrash
KPKanitha Phalakornkule
Kanitha Phalakornkule
JCJanet S Carpenter
Janet S Carpenter
JJJosette Jones
Josette Jones
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.

27 May 2014 in Clinical Journal of Oncology Nursing
Verified
Journal Article
Closed access
Suhila SawesiSuhila Sawesi
Suhila Sawesi
JCJanet S. Carpenter
Janet S. Carpenter
JJJosette Jones
Josette Jones
Despite improved breast cancer survival rates with the use of tamoxifen and aromatase inhibitors, patients remain at risk for cancer recurrence and mortality because of nonadherence to medication. The objective of this review was to identify factors associated with nonadherence among patients with breast cancer. Electronic databases were searched for studies, and potentially relevant studies were retrieved and assessed for eligibility. Potential factors associated with nonadherence were identified, and they included patient-related factors (e.g., patient beliefs and knowledge, fear of adverse effects, forgetfulness, smoking, age, race), therapy-related factors (e.g., duration, side effects, additional prescribed medications, treatment interfering with lifestyle), healthcare system factors (e.g., patient/provider relationships), socioeconomic factors (e.g., medication costs, burden, scheduling problems, religion, marital status), and disease-related factors (e.g., comorbidities, stage of breast cancer). Those findings highlight the need for development of interventions to promote long-term adherence in patients with breast cancer.

27 October 2022 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
Suhila SawesiSuhila Sawesi
Suhila Sawesi
SMSridhar A. Malkaram
Sridhar A. Malkaram
ZEZakaria Y. Abd Elmageed
Zakaria Y. Abd Elmageed
Tamer FandyTamer Fandy
Tamer Fandy
Curcumin is a known epigenetic modifier that demonstrated antitumor effect in different types of cancer. The poor solubility and metabolic stability are major drawbacks that limit its development as an antitumor agent. Dimethoxycurcumin (DMC) is a more soluble and stable curcumin analog. In this study, we compared the effect of both drugs on a variety of histone posttranslational modifications and on the activity of histone lysine methyltransferase (HKMTs) and demethylase (HKDMTs) enzymes that target the H3K4, H3K9 and H3K27 epigenetic marks. Mass spectrometry was used to quantitate the changes in 95 histone posttranslational modifications induced by curcumin or DMC. The effect of both drugs on the enzymatic activity of HKMTs and HKDMs was measured using an antibody‐based assay. Mass spectrometry analysis showed that curcumin and DMC modulated several histone modifications. Histone changes were not limited to lysine methylation and acetylation but included arginine and glutamine methylation. Only few histone modifications were similarly changed by both drugs. On the contrary, the effect of both drugs on the activity of HKMTs and HKDMs was very similar. Curcumin and DMC inhibited the HKMTs enzymes that target the H3K4, H3K9 and H3K27 marks and increased the activity of the HKDMs enzymes LSD1, JARID and JMJD2. In conclusion, we identified novel enzymatic targets for both curcumin and DMC that support their use and development as epigenetic modifiers in cancer treatment. The multiple targets modulated by both drugs could provide a therapeutic advantage by overcoming drug resistance development.

7 September 2022 in Online Journal of Public Health Informatics
Verified
Journal Article
Closed access
PDF file
Suhila SawesiSuhila Sawesi
Suhila Sawesi
MRMohamed Rashrash
Mohamed Rashrash
ODOlaf Dammann
Olaf Dammann
Objective: To explore how disease-related causality is formally represented in current ontologies and identify their potential limitations. Methods: We conducted a systematic literature search on eight databases (PubMed, Institute of Electrical and Electronic Engendering (IEEE Xplore), Association for Computing Machinery (ACM), Scopus, Web of Science databases, Ontobee, Open Biological and Biomedical Ontology (OBO) Foundry, and Bioportal. We included studies published between January 1, 1970, and December 9, 2020, that formally represent the notions of causality and causation in the medical domain using ontology as a representational tool. Further inclusion criteria were publication in English and peer-reviewed journals or conference proceedings. Two authors (SS, RM) independently assessed study quality and performed content analysis using a modified validated extraction grid with pre-established categorization. Results: The search strategy led to a total of 8,501 potentially relevant papers, of which 50 met the inclusion criteria. Only 14 out of 50 (28%) specified the nature of causation, and only 7 (14%) included clear and non-circular natural language definitions. Although several theories of causality were mentioned, none of the articles offers a widely accepted conceptualization of how causation and causality can be formally represented. Conclusion: No current ontology captures the wealth of available concepts of causality. This provides an opportunity for the development of a formal ontology of causation/causality. ( 213 words)

28 March 2021 in Pharmacy
Verified
Journal Article
Open access
PDF file
MRMohamed Rashrash
Mohamed Rashrash
Suhila SawesiSuhila Sawesi
Suhila Sawesi
Jon SchommerJon Schommer
Jon Schommer
LBLawrence Brown
Lawrence Brown
Background: Knowing the type of pharmacy used by the patient is meaningful to the pharmacist. Previous studies have assessed different factors predicting the kind of pharmacy selection and reached inconsistent findings. Objectives: To identify patient and health-related factors associated with pharmacy type selection. Methods: The Andersen Behavioral Model of Health Service Use was used to organize the selection of patient characteristics and categorize them as predisposing, enabling, and need factors. The dependent variable was the type of pharmacy used. Logistic regression was used to predict the association between patient-related characteristics and the type of pharmacy used. Results: Older age respondents were less likely to use independent pharmacies (OR = 0.992) and more likely to use mail pharmacy services (OR = 1.026). Highly educated people showed higher use of chain and mail pharmacies (OR = 1.272, 1.185, respectively) and less tendency to use the independent, supermarket, and prescription-only pharmacy types. Men were less likely to use chain pharmacies (OR = 0.932) and more likely to use supermarket pharmacies than women. Patients who use Medication Therapy Management (MTM) services had higher odds of using independent and supermarket pharmacies (OR = 2.808, 1.689, respectively). Patients with a higher number of chronic diseases and experienced side effects of medications were more likely to use independent pharmacies (OR for number of disease = 1.097 and for side effects = 1.095). Conclusions: This study’s findings identify characteristics associated with selecting certain pharmacy settings and direct future research to include other predictors encompassing beliefs, attitudes, and other social factors.

29 May 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
Suhila SawesiSuhila Sawesi
Suhila Sawesi
AJArya Jadhav
Arya Jadhav
BRBushra Rashrash
Bushra Rashrash
Background: Leptospirosis, a zoonotic disease caused by Leptospira bacteria, continues to pose significant public health risks, particularly in tropical and subtropical regions. Objective: This systematic review aimed to evaluate the application of machine learning (ML) and deep learning (DL) techniques in predicting and diagnosing leptospirosis, focusing on the most used algorithms, validation methods, data types, and performance metrics. Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS), and Prediction model Risk of Bias Assessment Tool (PROBAST) tools, we conducted a comprehensive review of studies applying ML and DL models for leptospirosis detection and prediction, examining algorithm performance, data sources, and validation approaches. Results: Out of a total of 374 articles screened, 17 studies were included in the qualitative synthesis, representing approximately 4.5% of the initial pool. The review identified frequent use of algorithms such as support vector machines, artificial neural networks, decision trees, and convolutional neural networks (CNNs). Among the included studies, 88% (15/17) used traditional ML methods, and 24% (4/17) used DL techniques. Several models demonstrated high predictive performance, with reported accuracy rates ranging from 80% to 98%, notably with the U-Net CNN achieving 98.02% accuracy. However, public datasets were underused, with only 35% (6/17) of studies incorporating publicly available data sources; the majority (65%, 11/17) relied primarily on private datasets from hospitals, clinical records, or regional surveillance systems. Conclusions: ML and DL techniques demonstrate potential for improving leptospirosis prediction and diagnosis, but future research should focus on using larger, more diverse datasets, adopting transfer learning strategies, and integrating advanced ensemble and validation techniques to strengthen model accuracy and generalization.